Dom-LETROZOLE

Pharmascience is a leading Canadian privately owned pharmaceutical company and the largest pharmaceutical employer in Quebec. Established in 1983, the company develops, manufactures, and distributes a vast portfolio of generic and over-the-counter medications, as well as branded specialty products through its Pendopharm division. One of its notable generic offerings is Dom-LETROZOLE, an aromatase inhibitor used in the treatment of hormone-responsive breast cancer in postmenopausal women. With a global reach spanning over 50 countries, Pharmascience maintains sophisticated R&D and manufacturing facilities that adhere to international quality standards.